153 related articles for article (PubMed ID: 33423175)
1. Multidisciplinary Surgical Approach to Increase Complete Cytoreduction Rates for Advanced Ovarian Cancer in a Tertiary Gynecologic Oncology Center.
Mulligan KM; Glennon K; Donohoe F; O'Brien Y; Mc Donnell BC; Bartels HC; Vermeulen C; Walsh T; Shields C; McCormack O; Conneely J; Boyd WD; Mc Vey R; Mulsow J; Brennan DJ
Ann Surg Oncol; 2021 Aug; 28(8):4553-4560. PubMed ID: 33423175
[TBL] [Abstract][Full Text] [Related]
2. Extreme cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Outcomes from a single tertiary center.
Berger Y; Aycart S; Mandeli JP; Heskel M; Sarpel U; Labow DM
Surg Oncol; 2015 Sep; 24(3):264-9. PubMed ID: 26143715
[TBL] [Abstract][Full Text] [Related]
3. Cytoreduction (Peritonectomy Procedures) Combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Advanced Ovarian Cancer: Retrospective Italian Multicenter Observational Study of 511 Cases.
Di Giorgio A; De Iaco P; De Simone M; Garofalo A; Scambia G; Pinna AD; Verdecchia GM; Ansaloni L; Macrì A; Cappellini P; Ceriani V; Giorda G; Biacchi D; Vaira M; Valle M; Sammartino P
Ann Surg Oncol; 2017 Apr; 24(4):914-922. PubMed ID: 27896512
[TBL] [Abstract][Full Text] [Related]
4. The importance of primary tumor origin in gastrointestinal malignancies undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Leigh N; Solomon D; Pletcher E; Labow DM; Magge DR; Sarpel U; Golas BJ
World J Surg Oncol; 2020 Jul; 18(1):182. PubMed ID: 32703239
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant chemotherapy followed by hyperthermic intraperitoneal chemotherapy for patients with colorectal peritoneal metastasis: a retrospective study of its safety and efficacy.
Zhou S; Jiang Y; Liang J; Pei W; Zhou Z
World J Surg Oncol; 2021 May; 19(1):151. PubMed ID: 34001125
[TBL] [Abstract][Full Text] [Related]
6. Hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) with primary or secondary cytoreductive surgery in the treatment of advanced epithelial ovarian cancer.
Manzanedo I; Pereira F; Pérez-Viejo E; Serrano Á; Hernández-García M; Martínez-Torres B; Rihuete-Caro C; Calzas J; Cueto M
Minerva Ginecol; 2017 Apr; 69(2):119-127. PubMed ID: 27415829
[TBL] [Abstract][Full Text] [Related]
7. Minimally invasive secondary cytoreduction plus HIPEC versus open surgery plus HIPEC in isolated relapse from ovarian cancer: a retrospective cohort study on perioperative outcomes.
Fagotti A; Costantini B; Gallotta V; Cianci S; Ronsini C; Petrillo M; Pacciani M; Scambia G; Fanfani F
J Minim Invasive Gynecol; 2015; 22(3):428-32. PubMed ID: 25461683
[TBL] [Abstract][Full Text] [Related]
8. Impact of Previous Gynecologic Surgical Procedures on Outcomes of Non-Gynecologic Peritoneal Malignancies Mimicking Ovarian Cancer: Less Is More?
Guaglio M; Baratti D; Kusamura S; Reis ACV; Montenovo M; Bartolini V; Battaglia L; Deraco M
Ann Surg Oncol; 2021 May; 28(5):2899-2908. PubMed ID: 33641011
[TBL] [Abstract][Full Text] [Related]
9. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for management of recurrent/relapsed ovarian granulosa cell tumor: a single-center experience.
Al-Badawi IA; Abu-Zaid A; Azzam A; AlOmar O; AlHusaini H; Amin T
J Obstet Gynaecol Res; 2014 Sep; 40(9):2066-75. PubMed ID: 25181627
[TBL] [Abstract][Full Text] [Related]
10. Multidisciplinary Surgical Approach to Increase Survival for Advanced Ovarian Cancer in a Tertiary Gynaecological Oncology Centre.
Mulligan K; Corry E; Donohoe F; Glennon K; Vermeulen C; Reid-Schachter G; Thompson C; Walsh T; Shields C; McCormack O; Conneely J; Khan MF; Boyd WD; McVey R; O'Brien D; Treacy A; Mulsow J; Brennan DJ
Ann Surg Oncol; 2024 Jan; 31(1):460-472. PubMed ID: 37875740
[TBL] [Abstract][Full Text] [Related]
11. Routine ureteric stenting before cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in managing peritoneal carcinomatosis from gynecologic malignancies: a single-center experience.
Abu-Zaid A; Abou Al-Shaar H; Azzam A; AlOmar O; Al-Otaibi MF; Amin T; Al-Badawi IA
Ir J Med Sci; 2017 May; 186(2):269-273. PubMed ID: 27052968
[TBL] [Abstract][Full Text] [Related]
12. Repeated cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with recurrent peritoneal carcinomatosis.
Vassos N; Förtsch T; Aladashvili A; Hohenberger W; Croner RS
World J Surg Oncol; 2016 Feb; 14(1):42. PubMed ID: 26912149
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Factors and Significance of Gastrointestinal Leak After Cytoreductive Surgery (CRS) with Heated Intraperitoneal Chemotherapy (HIPEC).
Chouliaras K; Levine EA; Fino N; Shen P; Votanopoulos KI
Ann Surg Oncol; 2017 Apr; 24(4):890-897. PubMed ID: 27995450
[TBL] [Abstract][Full Text] [Related]
14. A guide to establishing a hyperthermic intraperitoneal chemotherapy program in gynecologic oncology.
Chambers LM; Costales AB; Crean-Tate K; Kuznicki M; Morton M; Horowitz M; Jagielo T; Rose PG; Michener C; Vargas R; Debernardo R
Gynecol Oncol; 2020 Sep; 158(3):794-802. PubMed ID: 32624234
[TBL] [Abstract][Full Text] [Related]
15. Is Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Justified for Biphasic Variants of Peritoneal Mesothelioma? Outcomes from the Peritoneal Surface Oncology Group International Registry.
Votanopoulos KI; Sugarbaker P; Deraco M; Morris D; Glehen O; Elias D; De Simone M; Robella M; Heyd B; Kusamura S; Baratti D; Chouliaras K; Russell G; Shen P; Levine EA;
Ann Surg Oncol; 2018 Mar; 25(3):667-673. PubMed ID: 29260418
[TBL] [Abstract][Full Text] [Related]
16. Indications for hyperthermic intraperitoneal chemotherapy with cytoreductive surgery: a systematic review.
Auer RC; Sivajohanathan D; Biagi J; Conner J; Kennedy E; May T
Eur J Cancer; 2020 Mar; 127():76-95. PubMed ID: 31986452
[TBL] [Abstract][Full Text] [Related]
17. A collaborative surgical approach to upper and lower abdominal cytoreductive surgery in ovarian cancer.
Eng OS; Raoof M; Blakely AM; Yu X; Lee SJ; Han ES; Wakabayashi MT; Yuh B; Lee B; Dellinger TH
J Surg Oncol; 2018 Jul; 118(1):121-126. PubMed ID: 29878375
[TBL] [Abstract][Full Text] [Related]
18. Diaphragmatic Peritonectomy and Full-Thickness Resection in CRS/HIPEC May Allow Higher Completeness of Cytoreduction Rates with a Low Rate of Respiratory Complications.
Craus-Miguel A; Segura-Sampedro JJ; González-Argenté X; Morales-Soriano R
Ann Surg Oncol; 2021 Aug; 28(8):4676-4682. PubMed ID: 33409735
[TBL] [Abstract][Full Text] [Related]
19. Sites of Recurrence After Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Patients with Peritoneal Carcinomatosis from Colorectal and Appendiceal Adenocarcinoma: A Tertiary Center Experience.
Feferman Y; Solomon D; Bhagwandin S; Kim J; Aycart SN; Feingold D; Sarpel U; Labow DM
Ann Surg Oncol; 2019 Feb; 26(2):482-489. PubMed ID: 30539491
[TBL] [Abstract][Full Text] [Related]
20. Outcomes for Elderly Ovarian Cancer Patients Treated with Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC).
Zambrano-Vera K; Sardi A; Lopez-Ramirez F; Sittig M; Munoz-Zuluaga C; Nieroda C; Gushchin V; Diaz-Montes T
Ann Surg Oncol; 2021 Aug; 28(8):4655-4666. PubMed ID: 33393042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
